newsfilter
← Latest News
GlobeNewswire·

Immutep Quarterly Activities Report Q1 FY27

Media Release Immutep intends to focus the registration-directed clinical development of efti on HNSCC in patients with CPS <1 and the neoadjuvant setting of STS, with preparations for future clinical trials